Global Regenerative Therapies for Osteoarthritis Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 93

Report ID: 27337

Osteoarthritis is a type of joint disease that results from breakdown of joint cartilage and underlying bone.
The increasing incidence of osteoarthritis is expected to drive the regenerative therapies for osteoarthritis market.
In 2018, the global Regenerative Therapies for Osteoarthritis market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Regenerative Therapies for Osteoarthritis status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Regenerative Therapies for Osteoarthritis development in United States, Europe and China.

The key players covered in this study
Acelity
Mesoblast
Nuo Therapeutics
Astellas Pharma
Organovo
Orgenesis
Sanofi
Athersys
Shire
Cytori Therapeutics

Market segment by Type, the product can be split into
Cell Therapy
Tissue Engineering
Gene Therapy

Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Orthopaedic Clinics
Research Institutes

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Regenerative Therapies for Osteoarthritis status, future forecast, growth opportunity, key market and key players.
To present the Regenerative Therapies for Osteoarthritis development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Regenerative Therapies for Osteoarthritis are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Regenerative Therapies for Osteoarthritis Market Size Growth Rate by Type (2014-2025)
1.4.2 Cell Therapy
1.4.3 Tissue Engineering
1.4.4 Gene Therapy
1.5 Market by Application
1.5.1 Global Regenerative Therapies for Osteoarthritis Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Orthopaedic Clinics
1.5.5 Research Institutes
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Regenerative Therapies for Osteoarthritis Market Size
2.2 Regenerative Therapies for Osteoarthritis Growth Trends by Regions
2.2.1 Regenerative Therapies for Osteoarthritis Market Size by Regions (2014-2025)
2.2.2 Regenerative Therapies for Osteoarthritis Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Regenerative Therapies for Osteoarthritis Market Size by Manufacturers
3.1.1 Global Regenerative Therapies for Osteoarthritis Revenue by Manufacturers (2014-2019)
3.1.2 Global Regenerative Therapies for Osteoarthritis Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Regenerative Therapies for Osteoarthritis Market Concentration Ratio (CR5 and HHI)
3.2 Regenerative Therapies for Osteoarthritis Key Players Head office and Area Served
3.3 Key Players Regenerative Therapies for Osteoarthritis Product/Solution/Service
3.4 Date of Enter into Regenerative Therapies for Osteoarthritis Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Regenerative Therapies for Osteoarthritis Market Size by Type (2014-2019)
4.2 Global Regenerative Therapies for Osteoarthritis Market Size by Application (2014-2019)

5 United States
5.1 United States Regenerative Therapies for Osteoarthritis Market Size (2014-2019)
5.2 Regenerative Therapies for Osteoarthritis Key Players in United States
5.3 United States Regenerative Therapies for Osteoarthritis Market Size by Type
5.4 United States Regenerative Therapies for Osteoarthritis Market Size by Application

6 Europe
6.1 Europe Regenerative Therapies for Osteoarthritis Market Size (2014-2019)
6.2 Regenerative Therapies for Osteoarthritis Key Players in Europe
6.3 Europe Regenerative Therapies for Osteoarthritis Market Size by Type
6.4 Europe Regenerative Therapies for Osteoarthritis Market Size by Application

7 China
7.1 China Regenerative Therapies for Osteoarthritis Market Size (2014-2019)
7.2 Regenerative Therapies for Osteoarthritis Key Players in China
7.3 China Regenerative Therapies for Osteoarthritis Market Size by Type
7.4 China Regenerative Therapies for Osteoarthritis Market Size by Application

8 Japan
8.1 Japan Regenerative Therapies for Osteoarthritis Market Size (2014-2019)
8.2 Regenerative Therapies for Osteoarthritis Key Players in Japan
8.3 Japan Regenerative Therapies for Osteoarthritis Market Size by Type
8.4 Japan Regenerative Therapies for Osteoarthritis Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Regenerative Therapies for Osteoarthritis Market Size (2014-2019)
9.2 Regenerative Therapies for Osteoarthritis Key Players in Southeast Asia
9.3 Southeast Asia Regenerative Therapies for Osteoarthritis Market Size by Type
9.4 Southeast Asia Regenerative Therapies for Osteoarthritis Market Size by Application

10 India
10.1 India Regenerative Therapies for Osteoarthritis Market Size (2014-2019)
10.2 Regenerative Therapies for Osteoarthritis Key Players in India
10.3 India Regenerative Therapies for Osteoarthritis Market Size by Type
10.4 India Regenerative Therapies for Osteoarthritis Market Size by Application

11 Central & South America
11.1 Central & South America Regenerative Therapies for Osteoarthritis Market Size (2014-2019)
11.2 Regenerative Therapies for Osteoarthritis Key Players in Central & South America
11.3 Central & South America Regenerative Therapies for Osteoarthritis Market Size by Type
11.4 Central & South America Regenerative Therapies for Osteoarthritis Market Size by Application

12 International Players Profiles
12.1 Acelity
12.1.1 Acelity Company Details
12.1.2 Company Description and Business Overview
12.1.3 Regenerative Therapies for Osteoarthritis Introduction
12.1.4 Acelity Revenue in Regenerative Therapies for Osteoarthritis Business (2014-2019)
12.1.5 Acelity Recent Development
12.2 Mesoblast
12.2.1 Mesoblast Company Details
12.2.2 Company Description and Business Overview
12.2.3 Regenerative Therapies for Osteoarthritis Introduction
12.2.4 Mesoblast Revenue in Regenerative Therapies for Osteoarthritis Business (2014-2019)
12.2.5 Mesoblast Recent Development
12.3 Nuo Therapeutics
12.3.1 Nuo Therapeutics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Regenerative Therapies for Osteoarthritis Introduction
12.3.4 Nuo Therapeutics Revenue in Regenerative Therapies for Osteoarthritis Business (2014-2019)
12.3.5 Nuo Therapeutics Recent Development
12.4 Astellas Pharma
12.4.1 Astellas Pharma Company Details
12.4.2 Company Description and Business Overview
12.4.3 Regenerative Therapies for Osteoarthritis Introduction
12.4.4 Astellas Pharma Revenue in Regenerative Therapies for Osteoarthritis Business (2014-2019)
12.4.5 Astellas Pharma Recent Development
12.5 Organovo
12.5.1 Organovo Company Details
12.5.2 Company Description and Business Overview
12.5.3 Regenerative Therapies for Osteoarthritis Introduction
12.5.4 Organovo Revenue in Regenerative Therapies for Osteoarthritis Business (2014-2019)
12.5.5 Organovo Recent Development
12.6 Orgenesis
12.6.1 Orgenesis Company Details
12.6.2 Company Description and Business Overview
12.6.3 Regenerative Therapies for Osteoarthritis Introduction
12.6.4 Orgenesis Revenue in Regenerative Therapies for Osteoarthritis Business (2014-2019)
12.6.5 Orgenesis Recent Development
12.7 Sanofi
12.7.1 Sanofi Company Details
12.7.2 Company Description and Business Overview
12.7.3 Regenerative Therapies for Osteoarthritis Introduction
12.7.4 Sanofi Revenue in Regenerative Therapies for Osteoarthritis Business (2014-2019)
12.7.5 Sanofi Recent Development
12.8 Athersys
12.8.1 Athersys Company Details
12.8.2 Company Description and Business Overview
12.8.3 Regenerative Therapies for Osteoarthritis Introduction
12.8.4 Athersys Revenue in Regenerative Therapies for Osteoarthritis Business (2014-2019)
12.8.5 Athersys Recent Development
12.9 Shire
12.9.1 Shire Company Details
12.9.2 Company Description and Business Overview
12.9.3 Regenerative Therapies for Osteoarthritis Introduction
12.9.4 Shire Revenue in Regenerative Therapies for Osteoarthritis Business (2014-2019)
12.9.5 Shire Recent Development
12.10 Cytori Therapeutics
12.10.1 Cytori Therapeutics Company Details
12.10.2 Company Description and Business Overview
12.10.3 Regenerative Therapies for Osteoarthritis Introduction
12.10.4 Cytori Therapeutics Revenue in Regenerative Therapies for Osteoarthritis Business (2014-2019)
12.10.5 Cytori Therapeutics Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details